Public Forum to Discuss Addiction as a Treatable Disease and Highlight National Alcohol and Drug Addiction Recovery Month

Thursday, September 13, 2007 General News
Email Print This Page Comment bookmark
Font : A-A+

Livonia, Mich., Sept. 12 /PRNewswire/-- To mark September as NationalAlcohol and Drug Recovery Month, local Detroit-area community leaders arehosting a public forum to discuss addiction treatment options and resourcesfor help. The forum will feature presentations by Donald Allen, Director ofthe Office of Drug Control Policy, local physicians, drug counselors and theLivonia Save Our Youth Task Force. As part of an education component, thepublic forum will present a 19-minute screening of this year's HBO ADDICTIONproject, a hard-hitting, 14-part, multi-media documentary series about thismisunderstood medical disease. Following is information about the event:

Media are invited to attend the forum and take this opportunity to give alocal voice to the problem of addiction and the recovery solution in Michigan.

The forum will also spotlight the harmful impact of drug dependence,including opioids (prescription painkillers such as oxycodone, fentanyl,hydrocodone and morphine do you need to reference copyrights here? as well asheroin). Local problems with opioid dependence reflect the national data onthis growing public health problem -- the Substance Abuse and Mental HealthServices Administration (SAMHSA) reports that approximately 5.2 million peoplecurrently misuse prescription pain relievers, second only to marijuana abuse.Additionally, nonmedical use of prescription drugs among young adultsincreased from 5.4 percent in 2002 to 6.4 percent in 2006, due largely to anincrease in the nonmedical use of opioid painkillers.

Resources for Opioid Dependence and Its Treatment

Any physician may take the training to become certified to treat opioid-dependent individuals with Suboxone(R) (buprenorphine HCl/naloxone HCldihydrate) C-III Sublingual Tablets, the only FDA-approved controlledmedication that can be prescribed in a doctor's private office and with take-home prescriptions, under special legislation.

Individuals who need more information about opioid dependence and itstreatment, either for themselves or for someone they are concerned about, haveseveral options.

Free educational Resource Kits on this topic can be obtained or by calling 1-866-455-TURN, both provided by ReckittBenckiser Pharmaceuticals. also offers a physician locatordesigned to help individuals find an area doctor available to prescribebuprenorphine.

The Addiction411 page is available on MySpace and offers direct access toinformation about this increasingly prevalent disease and practical guidanceon how to find treatment for opioid dependence. if you or someone you know would like to accessAddiction411.

Additionally, the non-profit patient advocacy group NAABT -- NationalAlliance of Advocates for Buprenorphine Treatment -- is dedicated to helpingeducate the public on opioid dependence and medical treatment in a privatedoctor's office. NAABT now offers a nationwide confidential matching serviceto pair individuals seeking buprenorphine treatment with available doctors;visit SAMHSA's Web site also provides a physician locator andother valuable information at

Partial funding for the event was made possible by Reckitt BenckiserPharmaceuticals Inc.

About Reckitt Benckiser Pharmaceuticals Inc.

Reckitt Benckiser Pharmaceuticals Inc. is a specialty pharmaceuticalcompany that markets Suboxone(R) (buprenorphine HCl/naloxone HCl dihydrate [2mg/0.5 mg and 8 mg/2 mg]) C-III Sublingual Tablets and Subutex(R)(buprenorphine HCl [2 mg and 8 mg]) C-III Sublingual Tablets, formulations ofbuprenorphine used to treat opioid dependence in a medical office-basedsetting. Suboxone and Subutex, manufactured by Reckitt Benckiser HealthcareLtd., are the only controlled medications under the Drug Addiction TreatmentAct of 2000 approved

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z


News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store